BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8246144)

  • 1. Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids.
    Szabo I; Rojavin M; Bussiere JL; Eisenstein TK; Adler MW; Rogers TJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):703-6. PubMed ID: 8246144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of norepinephrine release from rat cortex slices by opioids: differences among agonists in sensitivities to antagonists suggest receptor heterogeneity.
    Kim KW; Cox BM
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1153-60. PubMed ID: 8263776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L; Lee NM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
    Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mu and kappa opioids on injury-induced microglial accumulation in leech CNS: involvement of the nitric oxide pathway.
    Yahyavi-Firouz-Abadi N; Tahsili-Fahadan P; Ostad SN
    Neuroscience; 2007 Feb; 144(3):1075-86. PubMed ID: 17169497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
    Tao R; Auerbach SB
    J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological evidence for a 7-benzylidenenaltrexone-preferring opioid receptor mediating the inhibitory actions of peptidic delta- and mu-opioid agonists on neurogenic ion transport in porcine ileal mucosa.
    Poonyachoti S; Portoghese PS; Brown DR
    J Pharmacol Exp Ther; 2001 May; 297(2):672-9. PubMed ID: 11303057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic actions of opioid receptor agonists in ventromedial hypothalamic neurons in estrogen- and oil-treated female mice.
    Devidze N; Zhang Q; Zhou J; Lee AW; Pataky S; Kow LM; Pfaff DW
    Neuroscience; 2008 Apr; 152(4):942-9. PubMed ID: 18343595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stimulatory effect of mu- and delta-opioid receptors on bovine pinealocyte melatonin synthesis.
    Chuchuen U; Ebadi M; Govitrapong P
    J Pineal Res; 2004 Nov; 37(4):223-9. PubMed ID: 15485547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
    Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
    Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential inhibitory effects of mu-opioids on substance P- and capsaicin-induced nociceptive behavior in mice.
    Watanabe H; Nakayama D; Yuhki M; Sawai T; Sakurada W; Katsuyama S; Hayashi T; Watanabe C; Mizoguchi H; Fujimura T; Sakurada T; Sakurada S
    Peptides; 2006 Apr; 27(4):760-8. PubMed ID: 16226344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences among mouse strains in the regulation by mu, delta 1 and delta 2 opioid receptors of striatal adenylyl cyclases activated by dopamine D1 or adenosine A2a receptors.
    Noble F; Cox BM
    Brain Res; 1996 Apr; 716(1-2):107-17. PubMed ID: 8738226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulatory effect of endogenous and exogenous opioids on the excitatory reflex pathway of the rat ileum.
    Allescher HD; Storr M; Brechmann C; Hahn A; Schusdziarra V
    Neuropeptides; 2000 Feb; 34(1):62-8. PubMed ID: 10688971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit.
    Feng P; Rahim RT; Cowan A; Liu-Chen LY; Peng X; Gaughan J; Meissler JJ; Adler MW; Eisenstein TK
    Eur J Pharmacol; 2006 Mar; 534(1-3):250-7. PubMed ID: 16513108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body temperature and analgesic effects of selective mu and kappa opioid receptor agonists microdialyzed into rat brain.
    Xin L; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1997 Apr; 281(1):499-507. PubMed ID: 9103537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
    Machelska H; Labuz D; Przewłocki R; Przewłocka B
    J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.